NASDAQ

Epizyme Reports Third Quarter 2017 Operating Results and Company Updates

Company Scheduled for First FDA Interaction for Tazemetostat in NHL in 4Q17 Chief Medical ...

Epizyme Reports Third Quarter 2017 Operating Results and Company Updates

Company Scheduled for First FDA Interaction for Tazemetostat in NHL in 4Q17 Chief Medical ...

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

BOSTON, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company ...

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

BOSTON, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company ...